🔗 Share this article

An underground economy for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.

Investigational Drug Acquiring Popularity Via Social Media

The experimental drug, which is still in research studies, is being advertised by social media influencers for its alleged weight-reducing properties. Viewers are urged to message these accounts directly for source information, while also obtaining discount codes.

Thriving Trade on Social Networks

Additionally, a robust market exists on messaging services, where communities with thousands of participants share “before and after” photos, administration instructions and assertions of rapid British shipping. Sellers promote the substance there before redirecting buyers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could assist individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Medical Professionals Voice Concerns

However, doctors and chemists have warned that the sale of what remains an unapproved drug in the UK is a cause for concern and could lead to users administering substances of uncertain source.

Several professionals stated the popularity for retatrutide could be connected to the rising cost of licensed weight loss products such as Mounjaro.

Legal Position and Implementation

Selling the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved medication that cannot be marketed or distributed for human use under the British medical regulations.

Some influencers attempt to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still breach medicines, advertising, and consumer regulations, risking penalties, prosecution or prison.

Service Response and Material Removal

According to TikTok, the platform has removed problematic content and prohibited associated keywords and search suggestions. The organization said it was dedicated to maintaining the service safe and allocating resources in enhancing enforcement strategies.

Online Trading Activities

Investigations also discovered groups with up to 9,000 members marketing the experimental drug using the platform's integrated search feature, which operates like a online catalog. Typing “retatrutide” instantly displays channels with thousands of users, populated with images of slimming results, glowing testimonials and step-by-step instructions for mixing or administering at residence.

After moments of joining one group, a seller posted WhatsApp details, where the majority of transactions occur. The seller provided an instruction manual and guaranteed shipping within 48 hours. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None inquired about weight, medical conditions or past usage.

Item Details and Costs

Inside these communities, messages display dark colored parcels with Royal Mail stickers, stating to contain new batches. One message read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at residence with sterile water, or pre-filled pens usually sold at 160 pounds for 20mg. When asked how much time a pen should be used, sellers give contradictory answers varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Measures

A spokesperson for the messaging service stated it actively moderated harmful material on its platform including material that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are administering materials they cannot confirm. Although the science behind retatrutide is sound, these digital products may not include what they claim,” stated a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in interest to current cost increases for approved weight-loss drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But fake treatments are highly dangerous. You cannot know what’s inside or whether the conditions they were made in was sterile,” she said.

Her staff has already seen patients injured by personal administration from unconfirmed suppliers. “We understand the disappointment, but buying from messaging apps or communication platforms is gambling with your well-being,” stated Wyllie. “These materials could be contaminated or improperly measured.”

Producer Statement

A representative from Eli Lilly stated the substance was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a company investigational substance not yet approved … may subject patients to potentially serious health risks”.